Proventys is a healthcare technology company providing advanced decision support solutions that help clinicians optimize treatment decisions with significant patient outcomes at stake.

We develop software-based, point-of-care solutions embedded with validated predictive models and other tools that help clinicians make treatment decisions individualized to the patient across a range of disease conditions. By bringing predictive technologies and personalized medicine to the point-of-care, we are determined to support the critical needs of clinicians and patients.

The company is backed by Burrill & Company, a leading life sciences private equity firm based in San Francisco, and has a strategic partnership with McKesson Corporation. The management team and Board of Directors consist of experienced healthcare industry veterans and leaders.